远见诊断与罗氏就PhasED-Seq™技术达成非霍奇金淋巴瘤领域授权协议 - 美国商业资讯
Foresight Diagnostics and Roche Enter Licensing Agreement for PhasED-Seq™ Technology in Non-Hodgkin's Lymphoma PR Newswire
Foresight Diagnostics and Roche Enter Licensing Agreement for PhasED-Seq™ Technology in Non-Hodgkin's Lymphoma PR Newswire